Friday, July 18, 2008

Which baby do you want? A dilemma for the 21st century parent-to-be

Nature News has an intriguing article on the next three decades of reproductive medicine: essentially a series of short musings from scientists working in the field about the issues we will be facing in 30 year's time.

It's worth reading through in full, but this statement from Susannah Baruch at Johns Hopkins caught my eye:
There's speculation that people will have designer babies, but I don't think the data are there to support that. The spectre of people wanting the perfect child is based on a false premise. No single gene predicts blondness or thinness or height or whatever the 'perfect baby' looks like. You might find genetic contributors but there are so many environmental factors too.

More likely is that you'll have a set of embryos and you'll know every single thing about every gene in every embryo. For example, one embryo will have three genes associated with tallness, two for weakness, three for poor vision and some for disease; and the second embryo will have some other set. They're very complicated data. This is not creating a baby from scratch. None of us is a perfect specimen and none of our embryos will be either. [my emphasis]
I'm unsure how selecting amongst these embryos doesn't count as making "designer babies" (it's still a choice, even if it's between a set of imperfect options), but I think Baruch's second paragraph is spot-on. It's clear from recent genome-wide association studies (GWAS) for height and weight that many (if not most) traits are hideously complex at the genetic level - a mess of common and rare genetic variants scattered throughout the genome, each contributing only the tiniest proportion of the overall variation.

Height is a great example: GWAS results from more than 30,000 individuals have uncovered dozens of contributing variants, which together predict less than 5% of the variation in height. There's no doubt we'll uncover much of the remaining variation with emerging technologies (analysis of structural variation, and large-scale sequencing) and larger cohorts, by which time we'll likely have hundreds of contributing variants. The same will hold more or less true for other complex traits, including susceptibility to common diseases like diabetes or hypertension.

The point is not that we will never understand the genetic basis of complex traits - we will, at least to a pretty good approximation, given advanced tools and sufficiently large cohorts. The point is that even once we understand the genetics of complex traits perfectly, that won't be enough to generate a "perfect baby" through embryo screening alone.

To illustrate this, imagine - ten or fifteen years from now - a couple who have just had IVF to generate perhaps two dozen embryos, and want to use genetic testing to decide which one(s) to implant. There won't be a single, stand-out embryo, perfect and disease-free, because generating a "perfect" embryo - one with the "desirable" variant at every single position in the genome - runs up against a pretty serious probabilistic challenge. Let's say there are only 5,000 DNA variants that negatively affected human health (an under-estimate) each with a frequency of just 1%: that means you would get a "perfect" embryo around once in every 1022 attempts (that's a 1 followed by 22 zeroes, a stupidly large number).

It's likely that methods to generate large numbers of embryos will be developed, particularly once stem cell technology enables sperm and egg cells to be created from adult tissue, but generating and screening 1022 embryos is no mean feat: at the rate of one every second, this would take you about 200,000,000,000,000 years, ten thousand times longer than the current age of the universe.

So it's safe to say that there will be no perfect baby. Instead, the prospective parents will face a tough choice between embryo A, who will likely be tall, slim, smart and cancer-free but have a higher-than-average chance of bipolar, early-onset dementia, and infertility; embryo B, who will be a little shorter, dark-haired, probably fairly gregarious, resistant to coronary artery disease, susceptible to bowel cancer, hypertension and early deafness; embryo C, who will be of average intelligence, unlikely to suffer premature baldness, prone to mild obesity and diabetes, but not at a high risk of any of the other major common diseases; and embryos D-N, who present a similar panel of competing probabilities.

Of course, a few embryos may carry mutations with known, severe health outcomes - those associated with rare diseases like muscular dystrophy, for instance. Embryo screening will have a very real impact on the frequencies of these conditions, just as we are already seeing following pre-natal diagnosis of conditions such as Down syndrome. But for the complex, common diseases there will be no easy answers; just a set of trade-offs.

The parents-to-be will sit down together with dossiers listing a huge set of statistical predictions for each of their potential children, and make a decision as to which (if any) of these abstract collections of traits and risks they wish to bring into this world. Decisions don't get much more emotionally traumatic than this: not only will they be making a decision that will shape their own lives and that of their future offspring, parents will carry a new, extra burden of responsibility for the fate of their children. If they decide on embryo A, and their child goes on to develop severe bipolar disease, they will carry the guilt of that decision in addition to the trauma of the disease itself.

That's not to say that embryo selection is unworkable - in fact, I think it's inevitable - but rather that this process is likely to require a degree of agonising trade-offs on the part of parents-to-be that is seldom fully appreciated. While I have no moral problem with the notion of embryo selection, part of me is glad that my child-bearing years are likely to be over before I have the chance to face this particular dilemma...


 Subscribe to Genetic Future.

11 comments:

TheGeneticGenealogist said...

Great article. For me, it seems more important to focus on altering traits on the other end of the lifespan spectrum, long after the baby is born. For instance, who cares if my baby has the baldness gene if a $50 gene therapy treatment when he turns 30 will ‘fix it’? Or who cares if my baby has a propensity for heart disease when we can just grow a new one? It seems to me that in the future parents will only make decisions about the variants/propensities for the worst diseases/conditions for which there is no known cure or prevention, and even those decisions may be unnecessary.

Indeed, you say that “parents will carry a new burden of responsibility for the fate of their children”, but that doesn’t fully take into account the speed with which science will use our new genetic knowledge to change the fate of our children long after they are born.

Daniel said...

Hi Blaine,

Excellent point - of course parents-to-be can console themselves with the notion that most of these conditions will have been rendered benign by medical advances by the time their child reaches the age where it matters.

However, that's assuming that they can afford the treatment - and this may only be true for the majority if public health and economic policies adapt as fast as medical science does, which is far from guaranteed. There's every chance that thirty years from now we will have effective treatments for all of these diseases that remain financially out of reach of a substantial fraction of the population.

So even with the prospect of cures for most common diseases within a generation there's still good reason to weigh up those probabilities carefully before deciding which embryo to implant: it's far better (and cheaper) for your offspring to grow up healthy without the need for serious, complex medical intervention, no matter how effective those interventions are.

TheGeneticGenealogist said...

I hope that the cost of these treatments (especially for life-threatening conditions) won’t ever be a problem, but realistically you’re right.

On the other hand, having treatments for conditions that could have been prevented by embryo sorting might console all the parents that want no part of embryo selection. Even if embryo picking becomes commonplace, there will undoubtedly be many millions of people who, for religions, personal, and ethical reasons, won’t choose to do so. These parents might have been faced with the guilt of passing along life-threatening genetic conditions, but with the advances in treatments that guilt will be alleviated. Again, however, money will play a part.

And some of this is also assuming that full-genome analysis will become the norm. It is very likely that many of the same parents who didn’t want to ‘embryo sort’ won’t want to analyze their children’s genomes, and will raise children who don’t want to analyze their genome. Or will genome analysis become so ingrained with healthcare that a person won’t be able to enter kindergarten at a public school until they’ve been sequenced (sort of like inoculation regulations), or get a flu shot at a clinic? I guess that’s a little off-topic, but I’ve enjoyed giving these issues some thought today. Thanks for a great article.

Daniel said...

Hi Blaine,

I don't think that the drive to adopt embryo screening technology will come from above (at least in Western democracies), but rather from parents themselves. Right now the technology seems alien and frightening, but familiarity will dull this edge with surprising speed (as it did for IVF). At the same time advances in reproductive technology will make it cheaper and less unpleasant to undergo IVF, dropping the major barrier to the widespread use of pre-implantation screening.

Parents will do just about anything to boost their children's chances of life success. I suspect that embryo selection to give your child "the best start in life" will become as routine and unremarkable - at least among the upper-middle-class who can afford it - as choosing a good school or getting your kids to eat their vegetables. Eventually it will seem irresponsible not to do it - why subject your children to a risk of serious disease or disability when you don't have to?

Religious and ethical objections will persist for a while, but history suggests that even strong religious objections tend to get steadily watered down over time if a taboo activity carries an obvious advantage. Moral righteousness over embryos starts to feel much less satisfying when it means missing out on a chance to reduce the risk of your children having autism and diabetes.

Kate said...

All of this is, of course, assuming that reproductive medicine will be able to ensure that any embryo *transferred* will actually *implant*, and having done so, will actually *grow* and result in a real, live baby.

No doubt the ordinary, run of the mill folks who want babies will be able to generate those large numbers of embryos, and have high probabilities of those embryos implanting and growing. However, as a survivor of the IVF wars, I can tell you that getting those embryos to begin with can be iffy, and just because you have pretty embryos doesn't mean you'll have a baby at the end.

And it will take quite a sea-change in popular culture to make in vitro a common alternative to just doing things the old-fashioned way, because of those aforementioned probabilities. Shooting yourself up with fertility drugs, submitting to transvaginal ultrasounds on a regular basis, dealing with egg retrieval, and coping with a BFN (big f'ing negative) when the pregnancy test comes along are all very emotionally charged steps. Sex, on the other hand, is comfortable, familiar, easy, and, most of all, fun.

To boot, the kind of people who will want designer babies are likely to be the kind of people who would want a *guaranteed* result. I foresee lawsuits against REs when the baby born ends up with red hair when blond was specified...

Steve Murphy MD said...

Hi all,
Daniel, what an excellent post. I wonder how aware people are of the increased risk of fetal anomalies, overgrowth syndromes akin to having a diabetic mother, and who knows what epigenetic changes there are. Did you guys know that there is significant evidence indicating these risks? In addition, did you know that the culture medium for cells are not the same for all embryos? In addition, it has never been appropriately studied. Even crazier, this week I just found out that Yale's REI specialists are not tracking outcomes in respect to these "congenital anomalies"

So I ask you....is red hair really worth it?????

-Steve
www.thegenesherpa.blogspot.com

Steve Murphy MD said...

IVF has many more hidden risks than are being shared. An N=1 at 30years of age is not a free license to start using this technology for genetic diseases which won't immediately affect the baby!
IMHO
-Steve
www.thegenesherpa.blogspot.com

Fly said...

TheGeneticGenealogist: "...but that doesn’t fully take into account the speed with which science will use our new genetic knowledge to change the fate of our children long after they are born."

Yes.

Stem cell lines will be used to produce unlimited quantities of specialized blood products. Some products will target cancers. Some products will cure diseases such as HIV or sickle cell anemia. Stem cell lines will produce unlimited quantities of tissue specific stem cells and progenitor cells. These will be used to repair damaged heart tissue, rebuild vascular systems, and cure diabetes. Stem cell lines will produce cells for organ regeneration and replacement. Stem cell lines will produce cells for tissue rejuvenation.

The technology for managing, monitoring, and growing stem cell lines, the technology for differentiating specific cell types, the technology for implanting those cells into the desired locations, and the technology to manage cell turnover in the tissues will advance becoming cheap, mass production medicine. (Imagine standardized cell lines for transplantation together with micro robotic surgery for implantation.)

People will grow accustomed to putting cells from donors into their own bodies. They will think of those new cells as their own body and won't care who originally carried the DNA. They will only care about the results they see in their own body. This will lead to totally body makeovers where most of the body cells are replaced with a new genotype.

Within thirty years some people will rebuild themselves using genetically engineered stem cells. Public acceptance will come from medical treatments, cosmetic enhancement, and rejuvenation.

Dan said...

Daniel, great post. The Nature article itself presents a wide range of predictions, some of which I find more astute than others. However, I think you nailed it on the head when you said that prospective parents will likely face a choice between embryo A (with certain traits and susceptibilities), embryo B (with other traits and susceptibilities), embryo C, etc.

Even in the post-genome era, human genetics is proving to be a probabilities game, certainly for complex traits. Most characteristics being discussed here (physical appearance, disease susceptibility, etc.) are complex traits, and if our ability to provide accurate probabilities for these based on a genome sequence proves accurate even three decades out, I'll be impressed.

A more difficult question to answer is whether or not prospective parents will take advantage of science and technology to even have the information. Currently embryonic tests for 20+ highly penetrant Mendelian disorders are available, yet many young couples that I know choose not to even have these done. The geneticist in me marvels at this. Why wouldn't you want to know in advance if your child will have cystic fibrosis?

I doubt that many prospective parents would balk at embryonic tests that help identify the most viable embryo. However, choosing embryos based on what traits or susceptibilities they may develop as adults seems to me to be far more difficult. Even with the availability of complete, affordable embryonic genome sequencing I expect that many parents will go without.

--
Dan Koboldt
MassGenomics
http://www.massgenomics.org

Steve Murphy MD said...

Dan and Daniel,
Any thoughts about how we handle the epigenetic issues?
-Steve

Daniel said...

Steve,

Sure, IVF is not risk-free, but I think it's a safe assumption that the risks will reduce as the technology improves. Kate's comment above also speaks to a number of other aspects of the IVF procedure (side-effects of hormonal treatments, invasive transvaginal ultrasounds, painful egg retrieval and the high failure rate) that would need to be improved before this option could possibly be more appealing than doing things the old-fashioned way; again, I think the commercial incentives will ensure that these improvements are made fairly speedily over the next decade or so.

Anyway, let's take these issues out of the equation and ask a simpler question: for a couple who are already having IVF, is it ethical to screen embryos for rare, fully penetrant disease genes? What about common, low-penetrance alleles for complex diseases? And what about non-disease traits? If they're already committed to taking all of the risks associated with IVF, is there anything wrong with using genetic screening to select which of their embryos they wish to implant first, using any trait they desire?